Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT)

Katalog der Deutschen Nationalbibliothek

Treffer 7762 von 8554


Link zu diesem Datensatz	https://d-nb.info/1118265831
Titel	Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT) / by Richard D. Carvajal, Gary K. Schwartz, Helen Mann, Ian Smith, Paul D. Nathan
Person(en)	Carvajal, Richard D. (Verfasser) Schwartz, Gary K. (Sonstige) Mann, Helen (Sonstige) Smith, Ian (Sonstige) Nathan, Paul D. (Sonstige)
Organisation(en)	SpringerLink (Online service) (Sonstige)
Umfang/Format	Online-Ressource : online resource.
Persistent Identifier	URN: urn:nbn:de:1111-2016110614172 DOI: 10.1186/s12885-015-1470-z
URL	http://dx.doi.org/10.1186/s12885-015-1470-z (Open Access)
Zeitliche Einordnung	Erscheinungsdatum: 2015
Sprache(n)	Englisch (eng)
Beziehungen	Enthalten in: BMC cancer (Bd. 15, 10.6.2015, Nr. 1, date:12.2015: 1-9)

Online-Zugriff

Archivobjekt öffnen

Treffer 7762 von 8554

Korrekturanfrage